A5014728738- Attention Deficit Hyperactivity Disorder
- Psychology Research and Bibliometrics
- Child and Adolescent Psychosocial and Emotional Development
- Psychological Treatments and Disorders
- Autism Spectrum Disorder Research
- Child and Adolescent Health
- Bipolar Disorder and Treatment
- Developmental and Educational Neuropsychology
- Health and Medical Education
- Childhood Cancer Survivors' Quality of Life
- Medicine and Dermatology Studies History
- Neural and Behavioral Psychology Studies
- Ethics and bioethics in healthcare
- Aging, Health, and Disability
- Children's Physical and Motor Development
- Suicide and Self-Harm Studies
- Family and Patient Care in Intensive Care Units
- Health and Lifestyle Studies
- Obstructive Sleep Apnea Research
- Treatment of Major Depression
- Child Nutrition and Feeding Issues
- Educational methodologies and cognitive development
- Helminth infection and control
- Urinary Bladder and Prostate Research
- Adolescent and Pediatric Healthcare
Hospital Materno-Infantil
1993-2020
Universitat Autònoma de Barcelona
2013-2016
Vall d'Hebron Hospital Universitari
2005-2015
Hospital Universitario de la Samaritana
2014
Hospital Universitario Virgen de las Nieves
2013
Objective. To evaluate the quality of life (QOL) untreated children with newly diagnosed attention-deficit/hyperactivity disorder (ADHD), compared asthmatic and healthy children. Methods. This prospective, case-control study included a group 120 children, 6 to 12 years age, ADHD according Diagnostic Statistical Manual Mental Disorders, Fourth Edition. Subjects were matched gender, health care area 2 control groups, ie, 93 Sociodemographic characteristics Child Health Questionnaire scores...
Attention-deficit/hyperactivity disorder (ADHD) is a common and highly heritable developmental characterized by persistent impairing pattern of inattention and/or hyperactivity-impulsivity. Using families from genetic isolate, the Paisa population Colombia, five independent datasets four different populations (United States, Germany, Norway Spain), consistent association was recently reported between ADHD latrophilin 3 (LPHN3) gene, brain-specific member LPHN subfamily G-protein-coupled...
To test the hypothesis that first-line treatment with atomoxetine provides superior efficacy than placebo for up to 12 weeks in improving symptoms of Attention Deficit/Hyperactivity Disorder (ADHD).This double-blind, randomized, placebo-controlled, parallel clinical trial included 151 treatment-naïve children (n = 113) and adolescents 38) newly diagnosed (< or =3 months) ADHD. Atomoxetine dose was uptitrated from 0.5 1.2 mg/kg/day after two weeks. Outcome assessments ADHD Rating...
Marta RibaséSab, Josep Antoni Ramos-Quirogaac, Amaia HerváSd, Cristina Sánchez-Moraabe, Rosa Boschac, Anna Bielsaa, Xavier Gastaminzaa, Klaus-Peter Leschf, Andreas Reiff, Tobias J. Rennerg, Marcel Romanosh, Warnkeg, Susanne Walitzagi, Christine Freitagj, Jobst Meyerk, Haukur Palmasonk, Miquel Casasac, Mònica Bayésl & Bru Cormand*emna Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spainb Psychiatric Genetics Unit, d'Hebron Research Institute (VHIR),...
This study investigated changes in the urine dihydroxyphenylglycol to norepinephrine ratio patients with attention-deficit hyperactivity disorder (ADHD) treated atomoxetine. The possible relationship clinical response was also explored. Newly ADHD diagnosed, treatment-naïve children or adolescents were double-blindly randomized (2:1) atomoxetine (n = 28) placebo 13). decreased both groups, showing significantly greater than at week 6 (-42% versus -14%; P .001), when dosed 1.2 mg/kg/day, 2...
In this article, the GEITDAH -the Spanish abbreviation of Special Interest Group on Attention Deficit Hyper-activity Disorder (ADHD)- presents a consensus reached by experts in management ADHD from all over Spain. The concerns fundamental aspects that should be starting point for future local or regional guides. Another aim is also to reduce amount variability occurs health care offered patients with our country, as well act stimulus educational matters. That fact it not very long will make...
La Asociación española de psiquiatría del niño y adolescente (AEPNyA) se fundó en Barcelona el año 1950 como una sociedad médica que tenía objetivo estudio los trastornos psiquiátricos niños adolescentes. Su desarrollo corre paralelo con la infantil europea. Los fundadores fueron hombres mujeres ilustrados, comprometidos su tiempo salud mental, educación derechos infancia. Este artículo aborda hitos principales historia AEPNyA distingue tres periodos: comienzos, fase afianzamiento madurez....
Existe un acuerdo científico generalizado acerca de que porcentaje elevado las personas presentan Trastorno por Déficit Atención con Hiperactividad (TDAH) tienen también importantes dificultades en su rendimiento psicológico. Esta afirmación cuenta evidencias cognitivo-conductuales y neurofuncionales. Así, están ampliamente constatados los problemas el funcionamiento ejecutivo pacientes TDAH, encontrándose, especial, tamaños efecto robustos para la memoria trabajo inhibición. En este se...
Introducción: el Síndrome Metabólico (SM) se caracteriza por obesidad, hiperglucemia o diabetes, hipertensión arterial y dislipidemia. La presencia de este síndrome incrementa riesgo enfermedades cardiovasculares, con consecuente aumento la mortalidad.
 Objetivo: determinar frecuencia del SM sus componentes en los trabajadores un hospital III nivel atención, utilizando tanto criterios Federación Internacional Diabetes (IDF) como definición unificada (armonizada).
 Metodología:...
In this paper, the Special Interest Group on Attention Deficit Hyperactivity Disorder (GEITDAH, from its name in Spanish) presents a consensus reached by experts all over Spain conduct disorders children and adolescents. Following initial work team at Pedopsychiatry Unit Quiron-Teknon Hospital Barcelona, agreements have been number of basic aspects that could be starting point for future consensuses. A top priority aim was also to update criteria Diagnostic statistical manual mental...
Introducción. El Trastorno por Déficit de Atención con Hiperactividad (TDAH) se asocia a importantes déficits en diversos dominios cognitivos. Dicha afirmación cuenta evidencias cognitivo-conductuales y neurofuncionales. tratamiento farmacológico indicado esta población tiene como objetivo fundamental suprimir o reducir la sintomatología nuclear del trastorno. Esta es diana terapéutica tanto Metilfenidato Atomoxetina. Ambos actúan sobre corteza prefrontal sus conexiones los ganglios basales,...